Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk
- PMID: 29209518
- PMCID: PMC5702952
- DOI: 10.1302/2058-5241.2.170005
Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk
Abstract
The relatively low incidence and often atypical clinical presentation of soft-tissue sarcomas (STS) impedes early and adequate diagnosis. Patients may report on recently enlarged soft-tissue swellings, infrequently complain of painful lesions, or even have no symptoms at all.A thorough diagnostic work-up is essential in order to distinguish between benign soft-tissue tumours and STSs. Patient history, clinical features and radiological findings all help in assessing the underlying pathology. 'Worrying' features such as recent increase in size, deep location relative to the fascia, a tumour exceeding 4 cm in size, and invasive growth patterns seen on imaging should prompt verification by biopsy.Even though acquisition of biopsy material may be incomplete, one should bear in mind some essential rules. Regardless of the biopsy technique applied, the most direct route to the lump in question should be identified, contamination of adjacent structures should be avoided and a sufficient amount of tissue acquired.Treatment of STS is best planned by a multidisciplinary team, involving experts from various medical specialities. The benchmark therapy consists of en bloc resection of the tumour, covered by a safety margin of healthy tissue. Depending on tumour histology, grade, local extent and anatomical stage, radiotherapy, chemotherapy and isolated hyperthermic limb perfusion may be employed.Due to the complexity of treatment, any soft-tissue swelling suspected of malignancy is best referred directly to a sarcoma centre, where therapeutic management is carefully planned by an experienced multidisciplinary team. Cite this article: EFORT Open Rev 2017;2:421-431. DOI: 10.1302/2058-5241.2.170005.
Keywords: diagnostic pathway; soft-tissue sarcoma; therapeutic management.
Conflict of interest statement
ICMJE Conflict of interest statement: Dr Leithner has recieved grants from Johnson & Johnson, Alphamed and Medtronic, activity outside the submitted work.
Figures







Similar articles
-
Soft tissue limb and trunk sarcomas: diagnosis, treatment and follow-up.Anticancer Res. 2014 Oct;34(10):5251-62. Anticancer Res. 2014. PMID: 25275017 Review.
-
Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.Acta Orthop Scand Suppl. 2001 Feb;72(300):1-31. Acta Orthop Scand Suppl. 2001. PMID: 11381580
-
[Surgery for soft-tissue sarcomas of the limbs and trunk wall].Cancer Radiother. 2016 Oct;20(6-7):657-65. doi: 10.1016/j.canrad.2016.07.068. Epub 2016 Sep 3. Cancer Radiother. 2016. PMID: 27599681 French.
-
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.Ann Surg Oncol. 2000 Mar;7(2):155-9. doi: 10.1007/s10434-000-0155-1. Ann Surg Oncol. 2000. PMID: 10761796
-
Brazilian consensus on the diagnosis and treatment of extremities soft tissue sarcomas.J Surg Oncol. 2020 Apr;121(5):743-758. doi: 10.1002/jso.25847. Epub 2020 Jan 22. J Surg Oncol. 2020. PMID: 31970785
Cited by
-
Combining Augmented Reality and 3D Printing to Improve Surgical Workflows in Orthopedic Oncology: Smartphone Application and Clinical Evaluation.Sensors (Basel). 2021 Feb 15;21(4):1370. doi: 10.3390/s21041370. Sensors (Basel). 2021. PMID: 33672053 Free PMC article.
-
Chronic Lower Limb Pain Unveiling a Rare Case of Spindle Cell Soft Tissue Sarcoma: A Diagnostic Odyssey.Cureus. 2023 Nov 10;15(11):e48634. doi: 10.7759/cureus.48634. eCollection 2023 Nov. Cureus. 2023. PMID: 38090440 Free PMC article.
-
Rethinking the Prognostic Role of Necrosis in Soft-Tissue Sarcoma: Multidisciplinary Insights from the Sarcoma Academy.Cancers (Basel). 2025 May 26;17(11):1779. doi: 10.3390/cancers17111779. Cancers (Basel). 2025. PMID: 40507260 Free PMC article.
-
Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: a case report.J Contemp Brachytherapy. 2021 Jun;13(3):338-346. doi: 10.5114/jcb.2021.106204. Epub 2021 May 18. J Contemp Brachytherapy. 2021. PMID: 34122575 Free PMC article.
-
Achieving a Good Response in Myxofibrosarcoma With Uncontrollable Bleeding Using an Enzyme-Targeting Radiosensitization Treatment: A Case Report.Cureus. 2025 Jan 21;17(1):e77800. doi: 10.7759/cureus.77800. eCollection 2025 Jan. Cureus. 2025. PMID: 39991348 Free PMC article.
References
-
- Casali PG, Blay JY, ESMO/CONTICANET/EUROBONET Consensus Panel of experts. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21:v198-v203. - PubMed
-
- Mandahl N. Soft tissue tumors: Lipoma/benign lipomatous tumors. Atlas Genet Cytogenet Oncol Haematol 2000;4:135-137.
-
- Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol 2010;21:1106-1111. - PubMed
-
- Clark MA, Thomas JM. Delay in referral to a specialist soft-tissue sarcoma unit. Eur J Surg Oncol 2005;31:443-448. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials